Cargando…

Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer

BACKGROUND: Several studies have demonstrated that circulating tumor DNA (ctDNA) can be used to predict the postoperative recurrence of several cancers. However, there are few studies on the use of ctDNA as a prognosis tool for gastric cancer (GC) patients. OBJECTIVE: This study aims to determine wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hekai, Liu, Houcong, Li, Jun, Wang, Jidong, Fu, Xiaohong, Li, Yingqiang, Mao, Shaolong, Du, Jihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349697/ https://www.ncbi.nlm.nih.gov/pubmed/37306927 http://dx.doi.org/10.1007/s13258-023-01412-7

Ejemplares similares

Immune dysregulation caused by homozygous mutations in CBLB
por: Janssen, Erin, et al.
Publicado: (2022)

Targeting CBLB as a Potential Therapeutic Approach for Disseminated Candidiasis
por: Xiao, Yun, et al.
Publicado: (2016)

cblb Gene Analysis in Japanese Type 1 Diabetes with Younger Age of Onset
por: Matsuda, Junko, et al.
Publicado: (2008)

Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition
por: Peer, Sebastian, et al.
Publicado: (2017)

Tumor rejection in Cblb(−/−) mice depends on IL-9 and Th9 cells
por: Schanz, Oliver, et al.
Publicado: (2021)

NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity
por: Lai, Lili, et al.
Publicado: (2019)

Spectrum and characterization of bi-allelic variants in MMAB causing cblB-type methylmalonic aciduria
por: Forny, Patrick, et al.
Publicado: (2021)

miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB
por: Yang, Song, et al.
Publicado: (2020)

Early cardiomyopathy without severe metabolic dysregulation in a patient with cblB‐type methylmalonic acidemia
por: Agnarsdóttir, Dagbjört, et al.
Publicado: (2022)

Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice
por: Hossain, Mohammad S., et al.
Publicado: (2014)

miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells
por: Chen, Danni, et al.
Publicado: (2018)

Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL)
por: Chen, Ke, et al.
Publicado: (2020)

Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB
por: Bruening, Janina, et al.
Publicado: (2018)

Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury
por: Melin, Nicolas, et al.
Publicado: (2021)

Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells
por: Li, Ting-Ting, et al.
Publicado: (2018)

CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy
por: Guo, Xuan, et al.
Publicado: (2021)

The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
por: Wang, Xiaohui, et al.
Publicado: (2023)

Postoperative high-density lipoprotein cholesterol level: an independent prognostic factor for gastric cancer
por: Li, Chenxi, et al.
Publicado: (2022)

Co‐recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR‐induced ubiquitylation
por: Voisinne, Guillaume, et al.
Publicado: (2016)

The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat Model
por: Wang, Dongdong, et al.
Publicado: (2016)

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
por: Valladares-Ayerbes, Manuel, et al.
Publicado: (2012)

Bta-miR-223 Targeting CBLB Contributes to Resistance to Staphylococcus aureus Mastitis Through the PI3K/AKT/NF-κB Pathway
por: Han, Shuo, et al.
Publicado: (2020)

Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model
por: Hinterleitner, Reinhard, et al.
Publicado: (2012)

Molecular and Circulating Biomarkers of Gastric Cancer
por: Jelski, Wojciech, et al.
Publicado: (2022)

May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?
por: Wu, Xiaoling, et al.
Publicado: (2015)

Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2021)

Circulating circERBB2 as a potential prognostic biomarker for gastric cancer: An investigative study
por: Nanishi, Kenji, et al.
Publicado: (2020)

Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer
por: Li, Chenxi, et al.
Publicado: (2023)

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
por: Liao, Hao, et al.
Publicado: (2022)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

The Prognostic Significance of Apoptosis-Related Biological Markers in Chinese Gastric Cancer Patients
por: Liu, Xiaowen, et al.
Publicado: (2011)

Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer
por: Liu, Wan-Li, et al.
Publicado: (2016)

Quantification of Tumor Abnormal Proteins in the Diagnosis and Postoperative Prognostic Evaluation of Gastric Cancer
por: Gu, Chao, et al.
Publicado: (2022)

Identifying an optimal machine learning model generated circulating biomarker to predict chronic postoperative pain in patients undergoing hepatectomy
por: Hong, Ying, et al.
Publicado: (2023)

miR-873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1
por: Gong, Hui, et al.
Publicado: (2018)

Krüppel-Like Factor 2 Is a Gastric Cancer Suppressor and Prognostic Biomarker
por: Li, Xi-mei, et al.
Publicado: (2023)

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
por: Zhang, Zihao, et al.
Publicado: (2022)

The prognostic value of postoperative tumor marker conversion for gastric cancer
por: Noh, Jeongju, et al.
Publicado: (2020)

ELP6 and PLIN5 Mutations Were Probably Prognostic Biomarkers for Patients With Gastric Cancer
por: Di, Ji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnrd2mcv4e18sgm23oqhdrltln